Clinical Trial Evaluating the Safety of the TQB2103 for Injection
Condition: Advanced Malignant Neoplasm Intervention: Drug: TQB2103 for injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials